Skip to main content

Advertisement

Open Peer Review Reports for: The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies:a meta-analysis

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
9 Jul 2018 Submitted Original manuscript
25 Jul 2018 Author responded Author comments - Hui Zhou
Resubmission - Version 2
25 Jul 2018 Submitted Manuscript version 2
16 Aug 2018 Reviewed Reviewer Report - Olga Sukocheva
5 Sep 2018 Author responded Author comments - Hui Zhou
5 Sep 2018 Reviewed Reviewer Report - Vladislav Korobeynikov
Resubmission - Version 3
5 Sep 2018 Submitted Manuscript version 3
10 Sep 2018 Author responded Author comments - Hui Zhou
Resubmission - Version 4
10 Sep 2018 Submitted Manuscript version 4
Publishing
13 Sep 2018 Editorially accepted
26 Sep 2018 Article published 10.1186/s12885-018-4817-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement